Radcliffe Capital Management, L.P. Ibere Pharmaceuticals Transaction History
Radcliffe Capital Management, L.P.
- $4.34 Million
- Q2 2024
Shares
2 transactions
Others Institutions Holding IBER
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About IBERE PHARMACEUTICALS
- Ticker IBER
- Exchange NYSE
- Sector Financial Services
- Industry Shell Companies
- Shares Outstandng 13,800,000
- Description
- Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.